As of 2025-07-01, the Relative Valuation of Integra Lifesciences Holdings Corp (IART) is (5.15) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.25 USD, the upside of Integra Lifesciences Holdings Corp based on Relative Valuation is -138.9%.
The range of the Relative Valuation is (13.39) - 6.33 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 35.9x - 43.5x | 42.4x |
| Forward P/E multiples | 30.8x - 40.4x | 35.0x |
| Fair Price | (13.39) - 6.33 | (5.15) |
| Upside | -201.1% - -52.2% | -138.9% |
| Date | P/E |
| 2025-06-26 | -32.77 |
| 2025-06-25 | -31.86 |
| 2025-06-24 | -31.86 |
| 2025-06-23 | -31.19 |
| 2025-06-20 | -31.13 |
| 2025-06-18 | -31.96 |
| 2025-06-17 | -32.61 |
| 2025-06-16 | -33.25 |
| 2025-06-13 | -32.64 |
| 2025-06-12 | -34.06 |
| 2025-06-11 | -34.43 |
| 2025-06-10 | -37.52 |
| 2025-06-09 | -37.25 |
| 2025-06-06 | -36.39 |
| 2025-06-05 | -35.67 |
| 2025-06-04 | -35.16 |
| 2025-06-03 | -35.00 |
| 2025-06-02 | -33.06 |
| 2025-05-30 | -33.98 |
| 2025-05-29 | -34.03 |
| 2025-05-28 | -34.08 |
| 2025-05-27 | -35.21 |
| 2025-05-23 | -33.01 |
| 2025-05-22 | -33.98 |
| 2025-05-21 | -34.06 |
| 2025-05-20 | -35.75 |
| 2025-05-19 | -36.37 |
| 2025-05-16 | -36.42 |
| 2025-05-15 | -34.92 |
| 2025-05-14 | -34.67 |
| 2025-05-13 | -36.26 |
| 2025-05-12 | -36.69 |
| 2025-05-09 | -32.88 |
| 2025-05-08 | -34.59 |
| 2025-05-07 | -34.17 |
| 2025-05-06 | -34.22 |
| 2025-05-05 | -35.64 |
| 2025-05-02 | -45.22 |
| 2025-05-01 | -44.12 |
| 2025-04-30 | -43.99 |
| 2025-04-29 | -46.56 |
| 2025-04-28 | -44.79 |
| 2025-04-25 | -45.12 |
| 2025-04-24 | -44.82 |
| 2025-04-23 | -43.64 |
| 2025-04-22 | -42.06 |
| 2025-04-21 | -40.77 |
| 2025-04-17 | -42.48 |
| 2025-04-16 | -42.27 |
| 2025-04-15 | -43.16 |